BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2495219)

  • 21. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris.
    Jansson JH; Nilsson TK; Olofsson BO
    Eur Heart J; 1991 Feb; 12(2):157-61. PubMed ID: 1904350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
    Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina.
    Masuda T; Yasue H; Ogawa H; Misumi I; Sakamoto T; Okubo H; Miyao Y; Kato H
    Am Heart J; 1992 Aug; 124(2):314-9. PubMed ID: 1636575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cigarette smoking impairs bradykinin-stimulated tissue plasminogen activator release in human coronary circulation.
    Takashima H; Matsumoto T; Nakae I; Yamane T; Horie M
    Thromb Res; 2007; 120(6):791-6. PubMed ID: 17328944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study on the reserve capacity of endothelial tissue plasminogen activator in patients with acute coronary syndrome].
    Yan J; Huang Z; Liu R; Li L; Han C; Yang J
    Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):817-20. PubMed ID: 11798724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm.
    Wanhainen A; Nilsson TK; Bergqvist D; Boman K; Björck M
    J Vasc Surg; 2007 Jun; 45(6):1109-13. PubMed ID: 17543671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.
    Smith AM; English KM; Malkin CJ; Jones RD; Jones TH; Channer KS
    Eur J Endocrinol; 2005 Feb; 152(2):285-91. PubMed ID: 15745938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease.
    Geppert A; Graf S; Beckmann R; Hornykewycz S; Schuster E; Binder BR; Huber K
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1634-42. PubMed ID: 9763537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tissue plasminogen activator, its inhibitor and other factors of the blood fibrinolytic system in stable coronary heart disease].
    Zateĭshchikov DA; Averkov OV; Gratsianskiĭ NA; Dobrovol'skiĭ AB; Storozhilova AN
    Kardiologiia; 1992 Feb; 32(2):9-12. PubMed ID: 1527946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of fibrinolytic system defectiveness in exercise induced myocardial ischemia and its mechanism].
    Deng H; Guo H; Qian X
    Zhonghua Nei Ke Za Zhi; 1995 May; 34(5):305-8. PubMed ID: 8565712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regular leisure time physical activity predicts high activity of tissue plasminogen activator: The Northern Sweden MONICA Study.
    Eliasson M; Asplund K; Evrin PE
    Int J Epidemiol; 1996 Dec; 25(6):1182-8. PubMed ID: 9027522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.
    Thøgersen AM; Söderberg S; Jansson JH; Dahlén G; Boman K; Nilsson TK; Lindahl B; Weinehall L; Stenlund H; Lundberg V; Johnson O; Ahrén B; Hallmans G
    Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):33-40. PubMed ID: 15167204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship of age, sex, body weight, smoking, blood lipids and fibrinolytic activities in healthy subjects].
    Xiong X; Wang Z; Zhao S
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):65-7. PubMed ID: 11938745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
    Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of niceritrol on fibrinolysis and lipoprotein (a) levels in patients with coronary artery disease.
    Suefuji H; Ogawa H; Yasue H; Imoto N; Sakamoto T; Miyao Y; Kaikita K; Soejima H; Nishiyama K
    Coron Artery Dis; 1996 Feb; 7(2):167-72. PubMed ID: 8813450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.
    Mehta J; Mehta P; Lawson D; Saldeen T
    J Am Coll Cardiol; 1987 Feb; 9(2):263-8. PubMed ID: 3100598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
    Aznar J; Estellés A; Tormo G; Sapena P; Tormo V; Blanch S; España F
    Br Heart J; 1988 May; 59(5):535-41. PubMed ID: 3132963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship of lipoprotein(a) to fibrinolytic activities in healthy subjects].
    Xiong X; Zhao S; Wang Z; Lo L; Huang Q
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):555-7. PubMed ID: 10806767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of low-level laser therapy as an adjunct to non-surgical periodontal treatment on gingival crevicular fluid levels of transforming growth factor-beta 1, tissue plasminogen activator and plasminogen activator inhibitor 1 in smoking and non-smoking chronic periodontitis patients: A split-mouth, randomized control study.
    Pamuk F; Lütfioğlu M; Aydoğdu A; Koyuncuoglu CZ; Cifcibasi E; Badur OS
    J Periodontal Res; 2017 Oct; 52(5):872-882. PubMed ID: 28394081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.